Safety of empagliflozin in patients with type 2 diabetes and chronic kidney disease: pooled analysis of placebo-controlled clinical trials : cardiovascular and metabolic risk - Tuttle, Katherine R.; Levin, Adeera; Nangaku, Masaomi; Kadowaki, Takashi; Agarwal, Rajiv; Hauske, Sibylle J.; Elsäßer, Amelie; Ritter, Ivana; Steubl, Dominik; Wanner, Christoph; Wheeler, David C. (Diabetes care, 2022)
Gesehen am 12.02.2024